Chris G. Adigun, MD

Clinical Trial Designs for Topical Antifungal Treatments of Onychomycosis and Implications on Clinical Practice

Author:: Phoebe Rich, MD; Tracey C. Vlahovic, DPM; Warren S. Joseph, DPM; Lee T. Zane, MD; Steve B. Hall, PharmD; Nicole Gellings Lowe, PhD; Chris G. Adigun, MD

There currently are 3 topical agents approved by the US Food and Drug Administration (FDA) to treat onychomycosis: tavaborole, efinaconazole, and...